Jason Zemansky
Stock Analyst at B of A Securities
(0.87)
# 2269
Out of 5,358 analysts
44
Total ratings
56.25%
Success rate
0.71%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Maintains: Buy | 32 9 | 3.06 | 194.12% | 1 | May 28, 2025 | |
CYTK Cytokinetics | Maintains: Neutral | 62 54 | 32.32 | 67.08% | 4 | Apr 15, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 29 31 | 15.31 | 102.48% | 4 | Apr 1, 2025 | |
INSM Insmed | Maintains: Strong Buy | 92 96 | 73.62 | 30.4% | 9 | Mar 20, 2025 | |
RCUS Arcus Biosciences | Maintains: Neutral | 22 17 | 9.96 | 70.68% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 29 | 6.72 | 331.55% | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 81 76 | 15.05 | 404.98% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 31 | 11.45 | 170.74% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 3 | 1.22 | 104.92% | 5 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 391 23 | n/a | n/a | 2 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 230 | n/a | n/a | 1 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 10 | 1.42 | 604.23% | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 450 162 | n/a | n/a | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 145 155 | n/a | n/a | 2 | Dec 13, 2021 |